Acquisition Extends Elsevier's Ability to Gather Global Healthcare News
and add to it in-Depth Analysis and Commentary That Will Dramatically
Increase Business Value for Customers
PHILADELPHIA, March 10 /CNW/ - Elsevier, the world's leading publisher of
science, technical and health information, announced today that it has
acquired Windhover Information Inc., a healthcare business intelligence
company that provides analysis and commentary on healthcare business strategy,
industry deal making, marketplace trends and medical start-ups.
The acquisition supports Elsevier's e-Health strategy to improve patient
healthcare and the business of health in the Pharma business intelligence
market. It expands Elsevier's offering of new products and services for Pharma
industry professionals by combining innovative technology and industry-leading
content to promote faster and better informed planning and management of
"Adding Windhover's expert analysis of the pharmaceutical and medical
device industries to our existing regulatory and general business news
services and database expands both the depth and breadth of Elsevier's
customer offerings," said Brian Nairn, CEO of Elsevier Health Sciences.
"Windhover also provides an exciting platform for new products."
Windhover produces authoritative journals such as IN VIVO and the RPM
Report, the world's most comprehensive database of healthcare industry
transactions (Strategic Transactions Database), and a series of medical-device
and biopharmaceutical partnering and strategy conferences. With Windhover,
Elsevier will field a team of more than 100 journalists in bureaus covering
healthcare developments across the globe.
The acquisition of Windhover is Elsevier's latest in a series of highly
synergistic investments in content, workflow tools and e-Health services.
Windhover will operate within Elsevier's Pharma Business Intelligence Unit,
which includes F-D-C Reports, Inc. (including "The Pink Sheet" and "The Gray
Sheet") and Inteleos, a powerful drug development database.
"Elsevier is one of the few companies as dedicated to covering the
business of healthcare as Windhover is," said Roger Longman and David Cassack,
Managing Partners and co-founders of Windhover. "We're proud to align with The
Pink Sheet and other F-D-C Reports products and provide growth opportunities
for our staff."
Terms of the acquisition are not being disclosed.
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over
70 offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as Science Direct. (http://www.sciencedirect.com/), MDConsult
(http://www.mdconsult.com/), Nursing Consult (http://www.nursingconsult.com/)
Scopus (http://www.info.scopus.com/), bibliographic databases, and online
Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed
Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher
and information provider. Operating in the science and medical, legal,
education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL
(New York Stock Exchange).
For further information:
For further information: Tom Reller, Director of Corp. Relations,
Elsevier, (212) 462-1912, T.Reller@Elsevier.com